Nov 06 2023
Jazz DUET Study

Posted at Nov 06 2023
h in Clinical Trial by Cara Weaver

The DUET Study will evaluate daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), also known as JZP258, in people with idiopathic hypersomnia (IH) or narcolepsy (Type 1 or Type 2).

Interested in Participating?

To learn more about the DUET Study contact:
Clinical Trial Disclosure and Transparency
215-832-3750
ClinicalTrialDisclosure@JazzPharma.com

Additional study information is available at www.clinicaltrials.gov using the identifier NCT05875974

The full brochure can be found here

Print page

Nov 06 2023 Jazz DUET Study

2 events, 1

2 events, 1

2 events, 2

2 events, 2

2 events, 3

2 events, 3

1 event, 4

1 event, 4

1 event, 5

1 event, 5

2 events, 6

2 events, 6

0 events, 7

0 events, 7

2 events, 8

2 events, 8

2 events, 9

2 events, 9

2 events, 10

2 events, 10

1 event, 11

1 event, 11

1 event, 12

1 event, 12

1 event, 13

1 event, 13

0 events, 14

0 events, 14

2 events, 15

2 events, 15

2 events, 16

2 events, 16

2 events, 17

2 events, 17

1 event, 18

1 event, 18

1 event, 19

1 event, 19

1 event, 20

1 event, 20

0 events, 21

0 events, 21

2 events, 22

2 events, 22

2 events, 23

2 events, 23

3 events, 24

3 events, 24

1 event, 25

1 event, 25

1 event, 26

1 event, 26

2 events, 27

2 events, 27

Wake Up Narcolepsy 2024 National Summit

Wake Up Narcolepsy 2024 National Summit

Nov 06 2023
Jazz DUET Study